KDT Advisors’s Amgen AMGN Stock Holding History

KDT Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Buy	664 +14	+2%	+$4.79K	0.33%	71
2026 Q1	$229K	Hold	650	–	–	0.36%	68
2025 Q4	$213K	Buy	+650	New	+$206K	0.3%	70
2025 Q2	–	Sell	-650	Closed	-$203K	–	71
2025 Q1	$203K	Buy	+650	New	+$192K	0.3%	72

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KDT Advisors's AMGN Position: Q2 2026 in Review

KDT Advisors increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $4.79K and bringing the position to 664 shares worth $240K. The position accounts for 0.33% of the portfolio, ranked #71.

KDT Advisors first reported a position in AMGN in Q1 2025 and has held it in 4 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

KDT Advisors held 664 shares of Amgen worth $240K as of Q2 2026.
KDT Advisors bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
Amgen made up 0.33% of KDT Advisors's portfolio in Q2 2026, its #71 holding.
KDT Advisors first reported a position in Amgen in Q1 2025 and has held it in 4 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KDT Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.